Protein–Ligand Interaction
Detailed binding analysis, computational docking, and molecular modeling to characterize and optimize affinity.
ProLigand Nexus partners with biotech and pharma teams to accelerate drug discovery — from target characterization to lead optimization — with rigorous, publication-grade science.


Mission & Vision
We help biotech and pharmaceutical companies translate structural insight into actionable chemistry. Every engagement is led personally — no handoffs, no junior teams — combining two decades of protein science with a clear focus on what advances your pipeline.
Core Services
Engage us for a focused sprint or as an embedded scientific partner — scoped to fit your stage and runway.
Detailed binding analysis, computational docking, and molecular modeling to characterize and optimize affinity.
Custom assay development including fluorescence, ELISA and biophysical approaches tailored to your target.
Enzyme engineering, expression, purification and functional characterization for therapeutic and industrial use.
Structural analysis with state-of-the-art simulation, MD and structure prediction tools.
Strategic R&D management and mentorship for research teams navigating early discovery to lead optimization.
Robust, reproducible workflows — from feasibility to scale — designed to de-risk decision-making.
How We Work
Scoping call to map the scientific question, constraints and decision points.
A tailored plan — methods, milestones, deliverables and a fixed timeline.
Hands-on execution with weekly updates and full data transparency.
Clear, actionable recommendations to advance — or pivot — your program.
Let's collaborate
Whether you're validating a new modality or de-risking a clinical candidate, a 30-minute conversation is the fastest way to know if we're the right partner.
Email Dr. Ben Bdira